CME Group CME Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.76B+7.5% | $6.52B+6.4% | $6.4B+5.8% | $6.44B+11.2% | $6.28B+11.7% | ||
| $923.3M+8.5% | $907M+6.7% | $886.7M+5.3% | $867.9M+4.7% | $851M+2.5% | ||
| $150.2M+17.3% | $150.5M+13.4% | $136.5M+1.2% | $130.8M-3.9% | $128.1M-8.0% | ||
| $246.7M-7.0% | $248.5M-7.1% | $253M-9.4% | $260.2M-4.8% | $265.3M-2.6% | ||
| $2.33B+5.6% | $2.29B+4.2% | $2.24B+2.0% | $2.24B+3.8% | $2.2B+2.8% | ||
| $4.43B+8.6% | $4.23B+7.6% | $4.16B+8.0% | $4.21B+15.5% | $4.08B+17.2% | ||
| 65.6%+0.6pp | 64.9%+0.7pp | 65%+1.3pp | 65.3%+2.5pp | 64.9%+3.0pp | ||
| $175.3M+7.7% | $173.4M+7.8% | $170.4M+6.6% | $166.6M+4.6% | $162.7M+2.1% | ||
| $1.17B+96.6% | $1.1B+80.5% | $691.7M+14.7% | $640M+5.9% | $592.9M-5.7% | ||
| $385.9M+9.7% | $371.7M+5.9% | $374.7M+14.8% | $364.5M+14.9% | $351.9M+15.0% | ||
| —— | —— | —— | —— | —— | ||
| $1.33B+26.8% | $1.26B+23.9% | $1.08B+10.1% | $1.08B+14.3% | $1.05B+14.6% | ||
| $4.3B+18.5% | $4.07B+15.5% | $3.76B+8.6% | $3.77B+14.0% | $3.63B+13.4% | ||
| 63.6%+5.9pp | 62.5%+4.9pp | 58.8%+1.5pp | 58.4%+1.5pp | 57.7%+0.8pp | ||
| $11.72+17.9% | $11.16+15.4% | $10.32+8.5% | $10.33+13.9% | $9.94+13.1% | ||
| $11.80+18.4% | $11.18+15.4% | $10.33+8.4% | $10.35+14.0% | $9.97+13.4% | ||
| 1.4B+0.3% | 1.4B+0.1% | 1.4B+0.1% | 1.4B+0.1% | 1.4B+0.1% | ||
| 1.4B0.0% | 1.4B+0.1% | 1.4B+0.1% | 1.4B+0.1% | 1.4B+0.1% | ||
| $224.3M+1.2% | $223.4M+0.8% | $222.8M+0.4% | $222.3M-0.5% | $221.7M-1.5% | ||
| —— | —— | —— | —— | —— | ||
| $294.1M+12.2% | $283.2M+10.7% | $273.7M+10.1% | $268.9M+13.2% | $262.1M+15.6% | ||
| $175.3M+7.7% | $173.4M+7.8% | $170.4M+6.6% | $166.6M+4.6% | $162.7M+2.1% | ||
| $6.23B+59.8% | $5.74B+40.6% | $4.9B+16.0% | $4.37B-2.0% | $3.9B-21.8% | ||
| $381.2M+4.7% | $371M+4.4% | $358.4M+1.9% | $374.4M+12.2% | $364.1M+11.7% | ||
| -$5.28B-50.9% | -$4.83B-32.1% | -$4.41B-16.5% | -$3.93B+2.1% | -$3.5B+22.4% | ||
| $4.43B+8.6% | $4.23B+7.6% | $4.16B+8.0% | $4.21B+15.5% | $4.08B+17.2% | ||
| $4.6B+9.6% | $4.34B+7.2% | $4.27B+7.6% | $4.32B+14.8% | $4.19B+16.3% | ||
| $4.6B+9.6% | $4.34B+7.2% | $4.27B+7.6% | $4.32B+14.8% | $4.19B+16.3% | ||
| 68%+1.3pp | 66.5%+0.5pp | 66.7%+1.1pp | 67%+2.1pp | 66.7%+2.6pp | ||
| $4.43B+8.6% | $4.23B+7.6% | $4.16B+8.0% | $4.21B+15.5% | $4.08B+17.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CME Group's revenue?
- CME Group (CME) generated $6.8B in revenue over the trailing twelve months, up 7.5% year over year.
- Is CME Group profitable?
- CME Group reported $4.3B in net income over the trailing twelve months, a 63.6% net margin.
- What is CME Group's earnings per share?
- CME Group's diluted EPS over the trailing twelve months is $11.72.
- Where does CME Group's income statement data come from?
- Every line is extracted from CME Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
